Long-Term Outcomes of ABO-Incompatible Versus Compatible Living Donor Liver Transplantation
NCT ID: NCT07105085
Last Updated: 2025-08-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
511 participants
OBSERVATIONAL
2012-01-01
2025-07-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The study aims to compare overall survival and the incidence of biliary complications.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Study on the Clinical Outcomes of ABO-Incompatible Living Donor Liver Transplantation
NCT07273448
Adult-to-Adult Living Donor Liver Transplantation Study
NCT00096733
Donor and Recipient Mismatch in Liver Transplantation
NCT07250919
Survival and Quality of Life After Liver Transplantation in Patients Aged 65 and Over
NCT04754503
Left Lobe Versus Right Lobe in Adult Living Donor Liver Transplantation in Borderline GRWR
NCT06542913
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
living donor liver transplantation
other intervention cannot be applied.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Seoung Hoon Kim
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Seoung Hoon Kim
National Cancer Center, Korea
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Seoung Hoon kim, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
National Cancer Center
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NCC2023-0110
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.